ADAPTIMMUNE THERAPEUTICS-ADR (ADAP) Institutional Ownership
None of the superinvestors we track currently report ADAPTIMMUNE THERAPEUTICS-ADR (ADAP) in their latest SEC Form 13F filings.
13F filings cover institutional equity holdings and are reported quarterly with a delay. This stock may still have insider Form 4 activity or appear in future filings.
When tracked funds report positions in ADAPTIMMUNE THERAPEUTICS-ADR (ADAP), this page will show 13F-reported ownership trends, hedge fund exposure, portfolio concentration, historical 13F filings, and estimated holding performance.
Institutional Ownership Trend
| Portfolio quarter | Institutional holders | Total reported value | Total shares |
|---|---|---|---|
| Q3 2025 | 1 | $527,032 | 4,054,089 |
| Q2 2025 | 1 | $451,320 | 1,882,860 |
| Q1 2025 | 1 | $357,331 | 1,813,860 |
| Q4 2024 | 1 | $1,361,037 | 2,526,524 |
| Q3 2024 | 1 | $1,574,408 | 1,656,575 |
| Q2 2024 | 1 | $1,741,502 | 1,786,341 |
| Q1 2024 | 1 | $2,199 | 1,391,775 |
| Q4 2023 | 1 | $1,087 | 1,370,239 |
| Q3 2023 | 1 | $802 | 1,027,860 |
| Q2 2023 | 1 | $1,393 | 1,506,375 |
| Q1 2023 | 1 | $199 | 182,700 |
| Q4 2022 | 1 | $819 | 560,973 |
Related ADAP Institutional Insights:
- ADAP Institutional Ownership & Insiders Activity
- ADAP Institutional Ownership & 13F Activity
- ADAP Top Institutional Shareholders
- ADAP Institutional Buying Activity
- ADAP Institutional Selling Activity
- Institutional Portfolio Overlap & Shared Holdings
- ADAP Insider Trading & SEC Form 4 Activity
- Top Institutional Investor Stock Rankings